久光製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/03/24 | 4,960 | 5,020 | 4,440 | 4,505 | -190 | -4% | 232,100 |
2020/03/23 | 4,550 | 4,710 | 4,470 | 4,695 | +170 | +3.8% | 288,700 |
2020/03/19 | 4,555 | 4,660 | 4,470 | 4,525 | +180 | +4.1% | 431,200 |
2020/03/18 | 4,250 | 4,550 | 4,205 | 4,345 | +165 | +3.9% | 330,700 |
2020/03/17 | 3,805 | 4,225 | 3,775 | 4,180 | +270 | +6.9% | 322,700 |
2020/03/16 | 4,010 | 4,150 | 3,890 | 3,910 | -50 | -1.3% | 198,200 |
2020/03/13 | 3,870 | 4,045 | 3,725 | 3,960 | -190 | -4.6% | 256,800 |
2020/03/12 | 4,220 | 4,255 | 4,095 | 4,150 | -175 | -4% | 230,300 |
2020/03/11 | 4,385 | 4,455 | 4,325 | 4,325 | -105 | -2.4% | 157,600 |
2020/03/10 | 4,400 | 4,460 | 4,175 | 4,430 | +95 | +2.2% | 212,000 |
2020/03/09 | 4,440 | 4,450 | 4,280 | 4,335 | -220 | -4.8% | 145,900 |
2020/03/06 | 4,640 | 4,640 | 4,530 | 4,555 | -150 | -3.2% | 145,800 |
2020/03/05 | 4,795 | 4,795 | 4,655 | 4,705 | +5 | +0.1% | 198,800 |
2020/03/04 | 4,700 | 4,750 | 4,655 | 4,700 | -90 | -1.9% | 127,300 |
2020/03/03 | 4,950 | 4,965 | 4,785 | 4,790 | -105 | -2.1% | 210,300 |
2020/03/02 | 4,705 | 4,935 | 4,705 | 4,895 | +60 | +1.2% | 202,000 |
2020/02/28 | 4,830 | 4,870 | 4,750 | 4,835 | -135 | -2.7% | 259,500 |
2020/02/27 | 5,040 | 5,040 | 4,950 | 4,970 | -170 | -3.3% | 152,500 |
2020/02/26 | 5,160 | 5,160 | 5,060 | 5,140 | -90 | -1.7% | 225,900 |
2020/02/25 | 5,270 | 5,310 | 5,200 | 5,230 | -340 | -6.1% | 290,400 |
2020/02/21 | 5,520 | 5,610 | 5,520 | 5,570 | +40 | +0.7% | 124,200 |
2020/02/20 | 5,570 | 5,630 | 5,520 | 5,530 | +10 | +0.2% | 128,600 |
2020/02/19 | 5,510 | 5,540 | 5,490 | 5,520 | +70 | +1.3% | 103,800 |
2020/02/18 | 5,590 | 5,590 | 5,430 | 5,450 | -160 | -2.9% | 155,500 |
2020/02/17 | 5,630 | 5,630 | 5,560 | 5,610 | -120 | -2.1% | 107,000 |
2020/02/14 | 5,710 | 5,820 | 5,700 | 5,730 | ±0 | ±0% | 174,400 |
2020/02/13 | 5,710 | 5,780 | 5,640 | 5,730 | ±0 | ±0% | 135,700 |
2020/02/12 | 5,810 | 5,820 | 5,720 | 5,730 | -50 | -0.9% | 127,600 |
2020/02/10 | 5,770 | 5,780 | 5,730 | 5,780 | -50 | -0.9% | 107,100 |
2020/02/07 | 5,860 | 5,910 | 5,780 | 5,830 | +30 | +0.5% | 148,700 |
2020/02/06 | 5,770 | 5,860 | 5,760 | 5,800 | +160 | +2.8% | 198,700 |
2020/02/05 | 5,660 | 5,700 | 5,590 | 5,640 | +70 | +1.3% | 148,600 |
2020/02/04 | 5,520 | 5,590 | 5,480 | 5,570 | +40 | +0.7% | 143,200 |
2020/02/03 | 5,480 | 5,580 | 5,470 | 5,530 | -90 | -1.6% | 162,600 |
2020/01/31 | 5,660 | 5,740 | 5,610 | 5,620 | ±0 | ±0% | 167,600 |
2020/01/30 | 5,720 | 5,720 | 5,590 | 5,620 | -80 | -1.4% | 220,100 |
2020/01/29 | 5,610 | 5,740 | 5,580 | 5,700 | -90 | -1.6% | 212,400 |
2020/01/28 | 5,740 | 5,810 | 5,710 | 5,790 | -40 | -0.7% | 153,400 |
2020/01/27 | 5,790 | 5,840 | 5,720 | 5,830 | -90 | -1.5% | 205,900 |
2020/01/24 | 5,940 | 5,960 | 5,890 | 5,920 | -90 | -1.5% | 165,700 |
2020/01/23 | 6,000 | 6,020 | 5,930 | 6,010 | +30 | +0.5% | 127,300 |
2020/01/22 | 5,950 | 6,000 | 5,940 | 5,980 | +30 | +0.5% | 158,800 |
2020/01/21 | 6,000 | 6,020 | 5,920 | 5,950 | -50 | -0.8% | 113,500 |
2020/01/20 | 6,020 | 6,070 | 6,000 | 6,000 | -70 | -1.2% | 82,500 |
2020/01/17 | 6,110 | 6,120 | 6,060 | 6,070 | +40 | +0.7% | 128,300 |
2020/01/16 | 6,060 | 6,120 | 6,020 | 6,030 | +30 | +0.5% | 155,000 |
2020/01/15 | 5,980 | 6,030 | 5,960 | 6,000 | +60 | +1% | 195,300 |
2020/01/14 | 5,800 | 5,950 | 5,720 | 5,940 | +340 | +6.1% | 366,500 |
2020/01/10 | 5,420 | 5,600 | 5,410 | 5,600 | +180 | +3.3% | 165,100 |
2020/01/09 | 5,490 | 5,530 | 5,380 | 5,420 | +20 | +0.4% | 144,500 |
1251~
1300
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「久光薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
久光薬 | 443,700円 | +5.8% | +1.2% | 2.70% | 14.72倍 | 1.17倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
ロート | 241,800円 | +18.2% | +4.2% | 1.49% | 16.97倍 | 2.16倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
参天薬 | 147,400円 | 0.0% | +50.6% | 2.44% | 15.48倍 | 1.74倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
住友ファーマ | 94,100円 | +26.8% | - | 0.00% | 15.84倍 | 3.27倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ツムラ | 430,100円 | +20.9% | +87.3% | 3.16% | 9.61倍 | 1.11倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
市場注目の銘柄
チャート関連のコラム